Studying the impact of probiotic agents on the pathogenetic and clinical features of generalized periodontitis

Authors

DOI:

https://doi.org/10.14739/2310-1210.2024.6.309576

Keywords:

periodontitis, biofilms, clinical features, treatment protocols, probiotics

Abstract

Generalized periodontitis remains one of the most prevalent dental diseases, complications of which significantly deteriorate patients’ quality of life. Currently, the use of probiotic agents is considered a promising direction to enhance the effectiveness of non-surgical treatment of this pathology. Studying the impact of different probiotics on the pathogenetic and clinical features of generalized periodontitis will allow proposing optimized protocols for comprehensive treatment, reducing patient rehabilitation periods and improving the overall dental health of the population.

The aim of this study is to examine the influence of various probiotic agents on the pathogenetic and clinical characteristics, treatment effectiveness of generalized periodontitis in adult patients by analyzing professional scientific literature.

The literature review provides a brief overview of various probiotic groups and discusses pathogenetic mechanisms of their interaction with the microbiota of oral biofilms. The immunomodulatory mechanisms of probiotics on local and systemic immune responses in patients with generalized periodontitis, inhibition of enzymes responsible for bone tissue resorption, are presented. The analysis results of scientific sources regarding the dynamics of changes in clinical symptoms, microbiological, immunological, and biochemical parameters of saliva and blood serum in individuals with generalized periodontitis receiving comprehensive rehabilitation using probiotic agents compared to patients treated with traditional protocols are provided. The study highlights statistical differences in clinical and laboratory indicators of periodontitis progression at different treatment intervals.

Conclusions. The use of probiotic agents for treating patients with generalized periodontitis significantly influences the clinical course of the disease by altering the species composition of dental biofilms and modulating local immune and inflammatory reactions. However, the known results of experimental and clinical studies often have conflicting findings regarding the efficacy of specific probiotic strains and the duration of inflammatory process stabilization over extended periods after treatment, which means a further study is required.

Author Biographies

M. A. Luchynskyi, Ivan Horbachevsky Ternopil National Medical University of the Ministry of Health of Ukraine

MD, PhD, DSc, Professor, Head of the Department of Dental Therapy

O. O. Pompii, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, PhD, Associate Professor of the Department of Dentistry

A. P. Oshurko, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, PhD, Acting Head of the Department of Dentistry

E. S. Pompii, State Establishment “Lugansk State Medical University”, Rivne, Ukraine

MD, Assistant of the Department of Dentistry

References

  1. Ziuzin VO, Cherno VS, Cherno SV, Ziuzin DV, Muntian LY. [The incidence of the population of ukraine of inflammatory periodontal diseases, prediction and prevention of pathology in modern conditions]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu. 2021;6(2):125-32. Ukrainian. doi: https://doi.org/10.26693/jmbs06.02.125
  2. Basista AS. [Improving of diagnostic methods and treatment of periodontal diseases in patients with chronic tonsillitis] [dissertation on the Internet]. Chernivtsi: Bukovinian State Medical University; 2023 [cited 2024 Aug 5]. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0824U000497/
  3. Gnid MR. [Clinical and laboratory justification of prevention and treatment of periodontal tissue diseases in patients with gout] [dissertation on the Internet]. Lviv: Danylo Halytsky Lviv National Medical University; 2023 [cited 2024 Aug 5]. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0823U101801/
  4. Dankevych-Kharchyshyn IS. [Optimization of diagnosis and treatment of periodontal tissue diseases in patients with atherosclerosis] [dissertation on the Internet]. Lviv: Danylo Halytsky Lviv National Medical University; 2024 [cited 2024 Aug 5]. Ukrainian. Available from: https://nrat.ukrintei.ua/en/searchdoc/0824U002198/
  5. Abdullah FM, Hatim QY, Oraibi AI, Alsafar TH, Alsandook TA, Lutfi W, et al. Antimicrobial management of Dental infections: Updated review. Medicine. 2024;103(27):e38630. doi: https://doi.org/10.1097/MD.0000000000038630
  6. Potapchuk A, Rusyn V, Goncharuk-Khomyn M, Hegedus V. Prognosis of possible implant loss after immediate placement by the laboratorial blood analysis and evaluation of intraoperatively derived bone samples. J Int Dent Med Res. 2019;12(1):143-50. Available from: http://www.jidmr.com/journal/wp-content/uploads/2019/04/25-D18_816_Myroslav_Goncharuk_Khomyn.pdf
  7. Mashchenko I, Gudaryan A, Kucherenko T. [Clinical, immunological and metabolic features of accelerated and quickly progressing options of generalized periodontitis]. Suchasna stomatolohiia. 2020;0(4):26-32. Ukrainian. doi: https://doi.org/10.33295/1992-576X-2020-4-26
  8. Bustamante M, Oomah BD, Mosi‐Roa Y, Rubilar M, Burgos‐Díaz C. Probiotics as an adjunct therapy for the treatment of halitosis, dental caries and periodontitis. Probiotics Antimicrob Proteins. 2020;12(2):325-34. doi: https://doi.org/10.1007/s12602-019-9521-4
  9. Santonocito S, Giudice A, Polizzi A, Troiano G, Merlo EM, Sclafani R, et al. Cross-talk between diet and the oral microbiome: balance of nutrition on inflammation and immune system’s response during periodontitis. Nutrients. 2022;14(12):2426. doi: https://doi.org/10.3390/nu14122426
  10. Deandra FA, Ketherin K, Rachmasari R, Sulijaya B, Takahashi N. Probiotics and metabolites regulate the oral and gut microbiome composition as host modulation agents in periodontitis: A narrative review. Heliyon. 2023;9(2):e13475. doi: https://doi.org/10.1016/j.heliyon.2023.e13475
  11. Del Pilar Angarita-Díaz M, Fong C, Medina D. Bacteria of healthy periodontal tissues as candidates of probiotics: a systematic review. Eur J Med Res. 2024;29(1):328. doi: https://doi.org/10.1186/s40001-024-01908-2
  12. Sukhomlyn AA, Hordiienko LP, Sukhomlyn TA. Znachennia probiotykiv u korektsii patolohichnykh protsesiv v orhanakh porozhnyny rota (ohliad literatury) [The value of probiotics in the correction of pathological processes in the organs of the oral cavity (literature review)]. Pivdennoukrainskyi medichnyi naukovyi zhurnal. 2020;26:54-7. Ukrainian.
  13. Loban GA, Hancho OV, Petrushanko TO, Moshel TN. [Probiotic as oral cavity colonization resistance increasing factor]. Aktualni problemy suchasnoi medytsyny. 2023;23(1):79-83. Ukrainian. doi: https://doi.org/10.31718/2077-1096.23.1.79
  14. Yu X, Devine DA, Vernon JJ. Manipulating the diseased oral microbiome: The power of probiotics and prebiotics. J Oral Microbiol. 2024;16(1):2307416. doi: https://doi.org/10.1080/20002297.2024.2307416
  15. Mahdizade Ari M, Mirkalantari S, Darban-Sarokhalil D, Darbandi A, Razavi S, Talebi M. Investigating the antimicrobial and anti-inflammatory effects of Lactobacillus and Bifidobacterium spp. on cariogenic and periodontitis pathogens. Front Microbiol. 2024;15:1383959. doi: https://doi.org/10.3389/fmicb.2024.1383959
  16. Na HS, Kim SY, Han H, Kim HJ, Lee JY, Lee JH, et al. Identification of Potential Oral Microbial Biomarkers for the Diagnosis of Periodontitis. J Clin Med. 2020;9(5):1549. doi: https://doi.org/10.3390/jcm9051549
  17. Albuquerque-Souza E, Balzarini D, Ando-Suguimoto ES, Ishikawa KH, Simionato MR, Holzhausen M, et al. Probiotics alter the immune response of gingival epithelial cells challenged by Porphyromonas gingivalis. J Periodontal Res. 2019;54(2):115-27. doi: https://doi.org/10.1111/jre.12608
  18. Widyarman AS, Theodorea CF. Novel indigenous probiotic lactobacillus reuteri strain produces anti-biofilm reuterin against pathogenic periodontal bacteria. Eur J Dent. 2021;16(1):96-101. doi: https://doi.org/10.1055/s-0041-1731591
  19. Etebarian A, Sheshpari T, Kabir K, Sadeghi H, Moradi A, Hafedi A. Oral Lactobacillus species and their probiotic capabilities in patients with periodontitis and periodontally healthy individuals. Clin Exp Dent Res. 2023;9(5):746-56. doi: https://doi.org/10.1002/cre2.740
  20. Kuka GI, Gursoy H, Emekli-Alturfan E, Ustundag UV, Kuru B. Evaluation of nitric oxide levels in chronic periodontitis patients treated with initial periodontal therapy and probiotic food supplements: a double blind, randomized controlled clinical trial. Biotechnol Biotechnol Equip. 2019;33(1):974-9. doi: https://doi.org/10.1080/13102818.2019.1632740
  21. Schlagenhauf U, Rehder J, Gelbrich G, Jockel‐Schneider Y. Consumption of lactobacillus reuteri‐containing lozenges improves periodontal health in Navy sailors at sea: A randomized controlled trial. J Periodontol. 2020;91(10):1328-38. doi: https://doi.org/10.1002/JPER.19-0393
  22. Alshareef A, Attia A, Almalki M, Alsharif F, Melibari A, Mirdad B, et al. Effectiveness of probiotic lozenges in periodontal management of chronic periodontitis patients: Clinical and immunological study. Eur J Dent. 2020;14(02):281-7. doi: https://doi.org/10.1055/s-0040-1709924
  23. A AJ, Suresh A. Oral microbial shift induced by probiotic bacillus coagualans along with its clinical perspectives. J Oral Biol Craniofac Res. 2023;13(3):398-402. doi: https://doi.org/10.1016/j.jobcr.2023.03.013
  24. Chugh P, Dutt R, Sharma A, Bhagat N, Dhar MS. A critical appraisal of the effects of probiotics on Oral Health. J Func Foods. 2020;70:103985. doi: https://doi.org/10.1016/j.jff.2020.103985
  25. Petrushanko TO, Loban GA, Moshel TN, Hancho OV. Therapeutic potential of lactobacilli-based drug in the treatment of generalized periodontitis. World of Medicine and Biology. 2020;(4):121-5. doi: https://doi.org/10.26724/2079-8334-2020-4-74-121-125
  26. Hardan L, Bourgi R, Cuevas-Suárez CE, Flores-Rodríguez M, Omaña-Covarrubias A, Nicastro M, et al. The use of probiotics as adjuvant therapy of periodontal treatment: A systematic review and meta-analysis of clinical trials. Pharmaceutics. 2022;14(5):1017. doi: https://doi.org/10.3390/pharmaceutics14051017
  27. Invernici MM, Furlaneto FA, Salvador SL, Ouwehand AC, Salminen S, Mantziari A, et al. Bifidobacterium animalis subsp Lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients. PLoS One. 2020;15(9):e0238425. doi: https://doi.org/10.1371/journal.pone.0238425
  28. Cafiero C, Spagnuolo G, Marenzi G, Martuscelli R, Colamaio M, Leuci S. Predictive periodontitis: The most promising salivary biomarkers for early diagnosis of periodontitis. J Clin Med. 2021;10(7):1488. doi: https://doi.org/10.3390/jcm10071488
  29. Luchian I, Goriuc A, Sandu D, Covasa M. The role of matrix metalloproteinases (MMP-8, MMP-9, MMP-13) in periodontal and peri-implant pathological processes. Int J Mol Sci. 2022;23(3):1806. doi: https://doi.org/10.3390/ijms23031806
  30. Khuda F, Najmi Mohamad Anuar N, Baharin B, Shaqinah Nasruddin N. A mini review on the associations of matrix metalloproteinases (mmps) -1, -8, -13 with periodontal disease. AIMS Molecular Science. 2021;8(1):13-31. doi: https://doi.org/10.3934/molsci.2021002
  31. Checchi V, Maravic T, Bellini P, Generali L, Consolo U, Breschi L, et al. The Role of Matrix Metalloproteinases in Periodontal Disease. Int J Environ Res Public Health. 2020;17(14):4923. doi: https://doi.org/10.3390/ijerph17144923
  32. Elgezawi M, Haridy R, Almas K, Abdalla MA, Omar O, Abuohashish H, et al. Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects. Int J Mol Sci. 2022;23(16):8929. doi: https://doi.org/10.3390/ijms23168929
  33. Laleman I, Pauwels M, Quirynen M, Teughels W. A dual‐strain lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial. J Clin Periodontol. 2019;47(1):43-53. doi: https://doi.org/10.1111/jcpe.13198
  34. Nisha K, Jebin A, Padmanabhan S. Oral Microbial Shift following 1-month supplementation of probiotic chewable tablets containing lactobacillus reuteri UBLRU-87 as an adjunct to phase 1 periodontal therapy in chronic periodontitis patients: A randomized controlled clinical trial. Contemp Clin Dent. 2021;12(2):121-7. doi: https://doi.org/10.4103/ccd.ccd_135_20
  35. Pelekos G, Acharya A, Eiji N, Hong G, Leung WK, McGrath C. Effects of adjunctive probiotic L. reuteri lozenges on S/RSD outcomes at molar sites with deep pockets. J Clin Periodont. 2020;47(9):1098-107. doi: https://doi.org/10.1111/jcpe.13329
  36. Bazyar H, Maghsoumi-Norouzabad L, Yarahmadi M, Gholinezhad H, Moradi L, Salehi P, et al. The impacts of synbiotic supplementation on periodontal indices and biomarkers of oxidative stress in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial. Diabetes Metab Syndr Obesity. 2020;13:19-29. doi: https://doi.org/10.2147/DMSO.S230060
  37. Di Stefano M, Polizzi A, Santonocito S, Romano A, Lombardi T, Isola G. Impact of Oral Microbiome in Periodontal Health and Periodontitis: A Critical Review on Prevention and Treatment. Int J Mol Sci. 2022;23(9):5142. doi: https://doi.org/10.3390/ijms23095142

Additional Files

Published

2024-12-04

How to Cite

1.
Luchynskyi MA, Pompii OO, Oshurko AP, Pompii ES. Studying the impact of probiotic agents on the pathogenetic and clinical features of generalized periodontitis. Zaporozhye Medical Journal [Internet]. 2024Dec.4 [cited 2026May21];26(6):490-5. Available from: https://zmj.zsmu.edu.ua/article/view/309576

Issue

Section

Review